(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

7TM ANTIBODIES

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

7TM ANTIBODIES

ST13

US500000079389375

Class

1

Filing

79389375

Registration

7602615

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

25

Latest update

04/03/2026

Trademark type

Combined

Nice classes

1

Filing date

12/11/2023

Registration date

12/17/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/17/2024

Last transaction

04/03/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

3

Owner type

27

Owner location

DE

Examiner

RIRIE, VERNA BETH

Law office

L40

Current location

FILE REPOSITORY (FRANCONIA)

Mark description

The mark consists of the stylized wording 7TM ANTIBODIES in the color gray with a black-colored circle extending from the bottom of the letter "M" following and a design resembling an antibody symbol in the color red to the right of the circle.

Holders and representatives

Holders

7TM Antibodies GmbH

Representatives

Timur Slonim Law Office of Timur E. Slonim, Esq.

Technical classification

Nice Classes

Class 1

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Antibody reagents for scientific purposes

Publications

History of USPTO decisions and trademark events.

25 publications found

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

08/01/2025

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

07/14/2025

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

07/14/2025

FINV

FINAL DECISION TRANSACTION PROCESSED BY IB

06/27/2025

FICS

FINAL DISPOSITION NOTICE SENT TO IB

06/07/2025

FIMP

FINAL DISPOSITION PROCESSED

06/06/2025

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

03/18/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

12/17/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

12/17/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

10/15/2024

PUBO

PUBLISHED FOR OPPOSITION

10/15/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

09/25/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/07/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/06/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/06/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

09/06/2024

RFNT

REFUSAL PROCESSED BY IB

08/25/2024

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

08/06/2024

RFRR

REFUSAL PROCESSED BY MPU

08/06/2024

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

07/19/2024

CNRT

NON-FINAL ACTION WRITTEN

07/18/2024

DOCK

ASSIGNED TO EXAMINER

07/09/2024

MAFR

APPLICATION FILING RECEIPT MAILED

02/20/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

02/16/2024

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

02/15/2024

Continuous trademark protection

Get notified about every new filing that threatens 7TM ANTIBODIES or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.